Skip to main content

Advertisement

SpringerLink
Log in

Ascorbic Acid Reverses Valproic Acid-Induced Inhibition of Hoxa2 and Maintains Glutathione Homeostasis in Mouse Embryos in Culture

  • Original Paper
  • Published:
Cellular and Molecular Neurobiology Aims and scope Submit manuscript

Abstract

Valproic acid (VPA) has been shown to cause neural tube defects in humans and mice, but its mechanism of action has not been elucidated. We hypothesize that alterations in embryonic antioxidant status and Hoxa2 gene expression play an important role in VPA-induced teratogenesis. A whole embryo culture system was applied to explore the effects of VPA on total glutathione, on glutathione in its oxidized (GSSG) and reduced (GSH) forms [GSSG/GSH ratio] and on Hoxa2 expression in cultured CD-1 mouse embryos during their critical period of organogenesis. Our results show that VPA can (1) induce embryo malformations including neural tube defects, abnormal flexion, yolk sac circulation defects, somite defects, and craniofacial deformities such as fusion of the first and second arches, and (2) alter glutathione homeostasis of embryos through an increase in embryonic GSSG/GSH ratio and a decrease in total GSH content in embryos. Western blot analysis and quantitative real-time RT-PCR show that VPA can inhibit Hoxa2 expression in cultured embryos at both the protein and mRNA level, respectively. The presence of ascorbic acid in the culture media was effective in protecting embryos against oxidative stress induced by VPA and prevented VPA-induced inhibition of Hoxa2 gene expression. Hoxa2 null mutant embryos do not exhibit altered glutathione homeostasis, indicating that inhibition of Hoxa2 is downstream of VPA-induced oxidative stress. These results are first to suggest VPA may, in part, exert its teratogenicity through alteration of the embryonic antioxidant status and inhibition of Hoxa2 gene expression and that ascorbic acid can protect embryos from VPA-induced oxidative stress.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  • Akin ZN, Nazarali AJ (2005) Hox genes and their candidate down stream targets in the developing central nervous system Cell. Mol Neurobiol 25:697–741

    Article  CAS  Google Scholar 

  • Al Deeb S, Al Moutaery K, Arshaduddin M, Tariq M (2000) Vitamin E decreases valproic acid induced neural tube defects in mice. Neurosci Lett 292:179–182

    Article  CAS  PubMed  Google Scholar 

  • Allen RG (1991) Oxygen-reactive species and antioxidant responses during development: the metabolic paradox of cellular differentiation. Proc Soc Exp Biol Med 196:117–129

    CAS  PubMed  Google Scholar 

  • Aoki Y, Okada A, Fujiwara M (2001) In vitro effects of anti-epileptic drugs (AEDs) on HOX gene expression in human EC cell line NT2/D1. The Japanese teratology society, 41st annual meeting, Congenit. Anomal (Kyoto), Abstract # O-38, 41:249

  • Baker MA, Cerniglia GJ, Zaman A (1990) Microtiter plate assay for the measurement of glutathione and glutathione disulfide in large numbers of biological samples. Anal Biochem 190:360–365

    Article  CAS  PubMed  Google Scholar 

  • Bannai S, Tateishi N (1986) Role of membrane transport in metabolism and function of glutathione in mammals. J Membr Biol 89:1–8

    Article  CAS  PubMed  Google Scholar 

  • Barnes GL, Mariani BD, Tuan RS (1996) Valproic acid-induced somite teratogenesis in the chick embryo: relationship with Pax-1 gene expression. Teratology 54:93–102

    Article  CAS  PubMed  Google Scholar 

  • Brown NA, Colhoun CW (1984) Valproic acid teratogenesis, 1. In vivo/in vitro comparisons and effects on somite morphogenesis. Teratology society 24th annual meeting program teratology. 29: Abstract# 20A–21A

  • Bruckner A, Lee YJ, O’Shea KS, Henneberry RC (1983) Teratogenic effects of valproic acid and diphenylhydantoin on mouse embryos in culture. Teratology 27:29–42

    Article  CAS  PubMed  Google Scholar 

  • Ceylan S, Duru S, Ceylan S (2001) Valproic acid sodium-induced spina bifida occulta in the rat. Neurosurg Rev 24:31–34

    Article  CAS  PubMed  Google Scholar 

  • Chang TK, Abbott FS (2006) Oxidative stress as a mechanism of valproic acid-associated hepatotoxicity. Drug Metab Rev 38:627–639

    Article  CAS  PubMed  Google Scholar 

  • Clayton-Smith J, Donnai D (1995) Fetal valproate syndrome. J Med Genet 32:724–727

    Article  CAS  PubMed  Google Scholar 

  • Cotariu D, Evans S, Zaidman JL, Marcus O (1990) Early changes in hepatic redox homeostasis following treatment with a single dose of valproic acid. Biochem Pharmacol 40:589–593

    Article  CAS  PubMed  Google Scholar 

  • Dawson JE, Raymond AM, Winn LM (2006) Folic acid and pantothenic acid protection against valproic acid-induced neural tube defects in CD-1 mice. Toxicol Appl Pharmacol 211:124–132

    Article  CAS  PubMed  Google Scholar 

  • Eikel D, Hoffmann K, Zoll K, Lampen A, Nau H (2006a) S-2-pentyl-4-pentynoic hydroxamic acid and its metabolite s-2-pentyl-4-pentynoic acid in the NMRI-exencephaly-mouse model: pharmacokinetic profiles, teratogenic effects, and histone deacetylase inhibition abilities of further valproic acid hydroxamates and amides. Drug Metab Dispos 34:612–620

    Article  CAS  PubMed  Google Scholar 

  • Eikel D, Lampen A, Nau H (2006b) Teratogenic effects mediated by inhibition of histone deacetylases: evidence from quantitative structure activity relationships of 20 valproic acid derivatives. Chem Res Toxicol 19:272–278

    Article  CAS  PubMed  Google Scholar 

  • Eyer P, Podhradsky D (1986) Evaluation of the micromethod for determination of glutathione using enzymatic cycling and Ellman’s reagent. Anal Biochem 153:57–66

    Article  CAS  PubMed  Google Scholar 

  • Faiella A, Wernig M, Consalez GG, Hostick U, Hofmann C, Hustert E, Boncinelli E, Balling R, Nadeau JH (2000) A mouse model for valproate teratogenicity: parental effects, homeotic transformations, and altered HOX expression. Hum Mol Genet 9:227–236

    Article  CAS  PubMed  Google Scholar 

  • Finnell RH (1991) Genetic differences in susceptibility to anticonvulsant drug-induced developmental defects. Pharmacol Toxicol 69:223–227

    CAS  PubMed  Google Scholar 

  • Freeman SJ, Steele CE (1986) Post-implantation whole embryo culture and the study of teratogenesis. Food Chem Toxicol 24:619–622

    Article  CAS  PubMed  Google Scholar 

  • Fuller LC, Cornelius SK, Murphy CW, Wiens DJ (2002) Neural crest cell motility in valproic acid. Reprod Toxicol 16:825–839

    Article  CAS  PubMed  Google Scholar 

  • Gendron-Maguire M, Mallo M, Zhang M, Gridley T (1993) Hoxa-2 mutant mice exhibit homeotic transformation of skeletal elements derived from cranial neural crest. Cell 75:1317–1331

    Article  CAS  PubMed  Google Scholar 

  • Graf WD, Oleinik OE, Glauser TA, Maertens P, Eder DN, Pippenger CE (1998) Altered antioxidant enzyme activities in children with a serious adverse experience related to valproic acid therapy. Neuropediatrics 29:195–201

    Article  CAS  PubMed  Google Scholar 

  • Griffith OW (1980) Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinylpyridine. Anal Biochem 106:207–212

    Article  CAS  PubMed  Google Scholar 

  • Hamza AA, Amin A (2007) Apium graveolens modulates sodium valproate-induced reproductive toxicity in rats. J Exp Zool Part A Ecol Genet Physiol 307:199–206

    Article  Google Scholar 

  • Hao Z, Yeung J, Wolf L, Doucette R, Nazarali A (1999) Differential expression of Hoxa-2 protein along the dorsal-ventral axis of the developing and adult mouse spinal cord. Dev Dyn 216:201–217

    Article  CAS  PubMed  Google Scholar 

  • Harris C, Stark KL, Juchau MR (1988) Glutathione status and the incidence of neural tube defects elicited by direct acting teratogens in vitro. Teratology 37:577–590

    Article  CAS  PubMed  Google Scholar 

  • Hegde KR, Varma SD (2004) Protective effect of ascorbate against oxidative stress in the mouse lens. Biochim Biophys Acta 1670:12–18

    CAS  PubMed  Google Scholar 

  • Held KD, Biaglow JE (1994) Mechanisms for the oxygen radical-mediated toxicity of various thiol-containing compounds in cultured mammalian cells. Radiat Res 139:15–23

    Article  CAS  PubMed  Google Scholar 

  • Hishida R, Nau H (1998) VPA-induced neural tube defects in mice. I. Altered metabolism of sulfur amino acids and glutathione. Teratog Carcinog Mutagen 18:49–61

    Article  CAS  PubMed  Google Scholar 

  • Hurd RW, Van Rinsvelt HA, Wilder BJ, Karas B, Maenhaut W, De Reu L (1984) Selenium, zinc, and copper changes with valproic acid: possible relation to drug side effects. Neurology 34:1393–1395

    CAS  PubMed  Google Scholar 

  • Hutter DE, Till BG, Greene JJ (1997) Redox state changes in density-dependent regulation of proliferation. Exp Cell Res 232:435–438

    Article  CAS  PubMed  Google Scholar 

  • Ingram JL, Rodier PM (1998) Valproic acid alters expression of Hoxa1 in rat embryos: a mechanism of teratogenesis? Teratology society: platform sessions abstracts. Teratology 57(4/5):191

    Google Scholar 

  • Jones BG, Rose FA, Tudball N (1994) Lipid peroxidation and homocysteine induced toxicity. Atherosclerosis 105:165–170

    Article  CAS  PubMed  Google Scholar 

  • Jurima-Romet M, Abbott FS, Tang W, Huang HS, Whitehouse LW (1996) Cytotoxicity of unsaturated metabolites of valproic acid and protection by vitamins C and E in glutathione-depleted rat hepatocytes. Toxicology 112:69–85

    Article  CAS  PubMed  Google Scholar 

  • Kultima K, Nyström A-M, Scholz B, Gustafson A-L, Dencker L, Stigson M (2004) Valproic acid teratogenicity: a toxicogenomics approach. Environ Health Perspect 112:1225–1235

    CAS  PubMed  Google Scholar 

  • Maconochie M, Krishnamurthy R, Nonchev S, Meier P, Manzanares M, Mitchell PJ, Krumlauf R (1999) Regulation of Hoxa2 in cranial neural crest cells involves members of the AP-2 family. Development 126:1483–1494

    CAS  PubMed  Google Scholar 

  • Mahmood R, Mason IJ, Morriss-Kay GM (1996) Expression of Fgf-3 in relation to hindbrain segmentation, otic pit position and pharyngeal arch morphology in normal and retinoic acid-exposed mouse embryos. Anat Embryol 194:13–22

    Article  CAS  PubMed  Google Scholar 

  • Menegola E, Broccia ML, Di Renzo F, Prati M, Giavini E (2000) In vitro teratogenic potential of two antifungal triazoles: triadimefon and triadimenol. In Vitro Cell Dev Biol Anim 36:88–95

    Article  CAS  PubMed  Google Scholar 

  • Menegola E, Di Renzo F, Broccia ML, Prudenziati M, Minucci S, Massa V, Giavini E (2005) Inhibition of histone deacetylase activity on specific embryonic tissues as a new mechanism for teratogenicity. Birth Defects Res B Dev Reprod Toxicol 74:392–398

    Article  CAS  PubMed  Google Scholar 

  • Michoulas A, Tong V, Teng XW, Chang TK, Abbott FS, Farrell K (2006) Oxidative stress in children receiving valproic acid. J Pediatr 149:692–696

    Article  CAS  PubMed  Google Scholar 

  • Miranda AF, Wiley MJ, Wells PG (1994) Evidence for embryonic peroxidase-catalyzed bioactivation and glutathione-dependent cytoprotection in phenytoin teratogenicity: modulation by eicosatetraynoic acid and buthionine sulfoximine in murine embryo culture. Toxicol Appl Pharmacol 124:230–241

    Article  CAS  PubMed  Google Scholar 

  • Na L, Wartenberg M, Nau H, Hescheler J, Sauer H (2003) Anticonvulsant valproic acid inhibits cardiomyocyte differentiation of embryonic stem cells by increasing intracellular levels of reactive oxygen species. Birth Defects Res A Clin Mol Teratol 67:174–180

    Article  CAS  PubMed  Google Scholar 

  • New DA (1978) Whole embryo culture and the study of mammalian embryos during organogenesis. Biol Rev Camb Philos Soc 53:81–122

    Article  CAS  PubMed  Google Scholar 

  • Nosel PG, Klein NW (1992) Methionine decreases the embryotoxicity of sodium valproate in the rat: in vivo and in vitro observations. Teratology 46:499–507

    Article  CAS  PubMed  Google Scholar 

  • Okada A, Kushima K, Aoki Y, Bialer M, Fujiwara M (2005) Identification of early-responsive genes correlated to valproic acid-induced neural tube defects in mice. Birth Defect Res A Clin Mol Teratol 73:229–238

    Article  CAS  Google Scholar 

  • Ornoy A (2006) Neuroteratogens in man: an overview with special emphasis on the teratogenicity of antiepileptic drugs in pregnancy. Reprod Toxicol 22:214–226

    Article  CAS  PubMed  Google Scholar 

  • Ozolinš TRS, Hales BF (1997) Oxidative stress regulates the expression and activity of transcription factor activator protein-1 in rat conceptus. J Pharmacol Exp Ther 280:1085–1093

    PubMed  Google Scholar 

  • Padmanabhan R, Ahmed I (1996) Sodium valproate augments spontaneous neural tube defects and axial skeletal malformations into mouse fetuses. Reprod Toxicol 10:345–363

    Article  CAS  PubMed  Google Scholar 

  • Pippenger CE, Meng XZ, Rothner AD, Cruse RP, Erenberg G, Solano R (1991) Free radical scavenging enzyme activity profiles in risk assessment of idiosyncratic drug reactions. In: Levy RH, Penry JK (eds) Idiosyncratic reactions to valproate: clinical risk patterns and mechanisms of toxicity. Raven Press, New York, pp 75–88

    Google Scholar 

  • Polifka JE, Friedman JM (2002) Medical genetics: 1. Clinical teratology in the age of genomics. CMAJ 167:265–273

    PubMed  Google Scholar 

  • Prince V, Lumsden A (1994) Hoxa2 expression in normal and transposed rhombomeres: independent regulation in the neural tube and neural crest. Development 120:911–923

    CAS  PubMed  Google Scholar 

  • Rijli FM, Mark M, Lakkaraju S, Dierich A, Dollé P, Chambon P (1993) A homeotic transformation is generated in the rostral branchial region of the head by disruption of Hoxa-2, which acts as a selector gene. Cell 75:1333–1349

    Article  CAS  PubMed  Google Scholar 

  • Samaei A, Nobahar M, Vafaei AA (2009) An experimental design for finding of minimum dosage of carbamazepine and valproate in preventing of seizure attacks. Pak J Pharm Sci 22:180–183

    CAS  PubMed  Google Scholar 

  • Santagati F, Minoux M, Ren S-Y, Rijli FM (2005) Temporal requirement of Hoxa2 in cranial neural crest skeletal morphogenesis. Development 132:4927–4936

    Article  CAS  PubMed  Google Scholar 

  • Seçkin S, Basaran-Küçükgergin C, Uysal M (1999) Effect of acute and chronic administration of sodium valproate on lipid peroxidation and antioxidant system in rat liver. Pharmacol Toxicol 85:294–298

    Article  PubMed  Google Scholar 

  • Sen CK, Packer L (1996) Antioxidant and redox regulation of gene transcription. FASEB J 10:709–720

    CAS  PubMed  Google Scholar 

  • Stodgell CJ, Ingram JL, O’Bara M, Tisdale BK, Nau H, Rodier PM (2006) Induction of the homeotic gene Hoxa1 through valproic acid’s teratogenic mechanism of action. Neurotoxicol Teratol 28:617–624

    Article  CAS  PubMed  Google Scholar 

  • Tabatabaei AR, Abbott FS (1999) LC/MS analysis of hydroxylation products of salicylate as an indicator of in vivo oxidative stress. Free Radic Biol Med 26:1054–1058

    Article  CAS  PubMed  Google Scholar 

  • Tietze F (1969) Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. Anal Biochem 27:502–522

    Article  CAS  PubMed  Google Scholar 

  • Tong V, Teng XW, Chang TK, Abbott FS (2005a) Valproic acid I: time course of lipid peroxidation biomarkers, liver toxicity, and valproic acid metabolite levels in rats. Toxicol Sci 86:427–435

    Article  CAS  PubMed  Google Scholar 

  • Tong V, Teng XW, Chang TK, Abbott FS (2005b) Valproic acid II: effects on oxidative stress, mitochondrial membrane potential, and cytotoxicity in glutathione-depleted rat hepatocytes. Toxicol Sci 86:436–443

    Article  CAS  PubMed  Google Scholar 

  • Trainor PA, Krumlauf R (2001) Hox genes, neural crest cells and branchial arch patterning. Curr Opin Cell Biol 13:698–705

    Article  CAS  PubMed  Google Scholar 

  • Van Maele-Fabry G, Delhaise F, Picard JJ (1990) Morphogenesis and quantification of the development of post-implantation mouse embryos. Toxicol In Vitro 4:149–156

    Article  Google Scholar 

  • Verrotti A, Scardapane A, Franzoni E, Manco R, Chiarelli F (2008) Increased oxidative stress in epileptic children treated with valproic acid. Epilepsy Res 78:171–177

    Article  CAS  PubMed  Google Scholar 

  • Wang X, Zhang W, Nazarali AJ (2007) Toxic effects of valproic acid on mouse palatal development in vitro. Proc. SECOTOX conference, Skiathos, Greece, vol 1, pp 139–144

  • Wegner C, Nau H (1991) Diurnal variation of folate concentrations in mouse embryo and plasma: the protective effect of folinic acid on valproic-acid-induced teratogenicity is time dependent. Reprod Toxicol 5:465–471

    Article  CAS  PubMed  Google Scholar 

  • Wilder BJ, Hurd RW (1991) Free radical scavenger deficiency and valproic acid. In: Levy RH, Penry JK (eds) Idiosyncratic reactions to valproate: clinical risk patterns and mechanisms of toxicity. Raven Press, New York, pp 89–95

    Google Scholar 

  • Williams JA, Mann FM, Brown NA (1997) Gene expression domains as markers in developmental toxicity studies using mammalian embryo culture. Int J Dev Biol 41:359–364

    CAS  PubMed  Google Scholar 

  • Yüksel A, Cengiz M, Seven M, Ulutin T (2001) Changes in the antioxidant system in epileptic children receiving antiepileptic drugs: two-year prospective studies. J Child Neurol 16:603–606

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

This study was funded by the Natural Sciences and Engineering Research Council of Canada (NSERC). Dr. Benzhong Zhang is recipient of a scholarship from the China Scholarship Council.

Author information

Authors and Affiliations

  1. Laboratory of Molecular Biology, College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, SK, S7N 5C9, Canada

    B. Zhang, X. Wang & A. J. Nazarali

  2. Department of Toxicology, College of Public Health, Lanzhou University, 730000, Lanzhou, Gansu, China

    B. Zhang

Authors
  1. B. Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. X. Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. J. Nazarali
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A. J. Nazarali.

Electronic supplementary material

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zhang, B., Wang, X. & Nazarali, A.J. Ascorbic Acid Reverses Valproic Acid-Induced Inhibition of Hoxa2 and Maintains Glutathione Homeostasis in Mouse Embryos in Culture. Cell Mol Neurobiol 30, 137–148 (2010). https://doi.org/10.1007/s10571-009-9438-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10571-009-9438-7

Keywords

Search

Navigation